RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CStone Pharmaceuticals Stock

CStone Pharmaceuticals ROA 2024

CStone Pharmaceuticals ROA

-0.22

Ticker

2616.HK

ISIN

KYG2588M1006

WKN

A2PEFW

In 2024, CStone Pharmaceuticals's return on assets (ROA) was -0.22, a -59.89% increase from the -0.55 ROA in the previous year.

CStone Pharmaceuticals Aktienanalyse

What does CStone Pharmaceuticals do?

CStone Pharmaceuticals is a biopharmaceutical company founded in January 2016 by a team of experienced industry leaders. The company is headquartered in Suzhou, China, and focuses on the discovery, development, and commercialization of innovative therapeutics in the fields of oncology, immunology, and metabolic disorders. CStone aims to improve healthcare worldwide and extend and enhance the lives of patients through the development of cutting-edge medical solutions. CStone Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding CStone Pharmaceuticals's Return on Assets (ROA)

CStone Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing CStone Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider CStone Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in CStone Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about CStone Pharmaceuticals stock

What is the Return on Assets (ROA) of CStone Pharmaceuticals this year?

The Return on Assets (ROA) of CStone Pharmaceuticals is -0.22 undefined this year.

What was the ROA of CStone Pharmaceuticals compared to the previous year?

The ROA of CStone Pharmaceuticals has increased by -59.89% compared to the previous year.

What consequences do high ROA have for investors of CStone Pharmaceuticals?

A high ROA is advantageous for investors of CStone Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in CStone Pharmaceuticals?

A low ROA can be unfavorable for investors of CStone Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of CStone Pharmaceuticals affect the company?

An increase in ROA of CStone Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of CStone Pharmaceuticals impact the company?

A reduction in the ROA of CStone Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of CStone Pharmaceuticals?

Some factors that can influence the ROA of CStone Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of CStone Pharmaceuticals important for investors?

The ROA of CStone Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can CStone Pharmaceuticals take to improve ROA?

To improve ROA, CStone Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does CStone Pharmaceuticals pay?

Over the past 12 months, CStone Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CStone Pharmaceuticals is expected to pay a dividend of 0 CNY.

What is the dividend yield of CStone Pharmaceuticals?

The current dividend yield of CStone Pharmaceuticals is .

When does CStone Pharmaceuticals pay dividends?

CStone Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CStone Pharmaceuticals?

CStone Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of CStone Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is CStone Pharmaceuticals located?

CStone Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von CStone Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CStone Pharmaceuticals from 9/9/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did CStone Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of CStone Pharmaceuticals in the year 2023?

In the year 2023, CStone Pharmaceuticals distributed 0 CNY as dividends.

In which currency does CStone Pharmaceuticals pay out the dividend?

The dividends of CStone Pharmaceuticals are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CStone Pharmaceuticals

Our stock analysis for CStone Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CStone Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.